Hologic, Inc.
HOLX
$60.70
-$0.40-0.66%
| Weiss Ratings | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.14 | |||
| Price History | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.57% | |||
| 30-Day Total Return | -15.00% | |||
| 60-Day Total Return | -19.16% | |||
| 90-Day Total Return | -25.20% | |||
| Year to Date Total Return | -15.39% | |||
| 1-Year Total Return | -20.48% | |||
| 2-Year Total Return | -22.48% | |||
| 3-Year Total Return | -12.77% | |||
| 5-Year Total Return | 49.58% | |||
| 52-Week High % Change | -27.84% | |||
| 52-Week Low % Change | 0.78% | |||
| Price | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $84.67 | |||
| 52-Week Low Price | $60.63 | |||
| 52-Week Low Price (Date) | Mar 12, 2025 | |||
| 52-Week High Price (Date) | Aug 09, 2024 | |||
| Valuation | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 13.71B | |||
| Enterprise Value | 14.27B | |||
| Price/Earnings (TTM) | 19.34 | |||
| Earnings Per Share (TTM) | 3.16 | |||
| Earnings Per Share Growth | 50.79% | |||
| Price/Earnings To Growth | 0.38 | |||
| Price/Sales (TTM) | 3.51 | |||
| Price/Book (Q) | 2.89 | |||
| Enterprise Value/Revenue (TTM) | 3.53 | |||
| Price | $60.70 | |||
| Enterprise Value/EBITDA (TTM) | 11.29 | |||
| Enterprise Value/EBIT | 14.61 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 232.11M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 508 263 2900 | |||
| Address | 250 Campus Drive Marlborough, MA 01752 | |||
| Website | www.hologic.com | |||
| Country | United States | |||
| Year Founded | 1985 | |||
| Profitability | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 24.19% | |||
| Profit Margin | 18.42% | |||
| Management Effectiveness | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.10% | |||
| Return on Equity | 15.78% | |||
| Income Statement | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.04B | |||
| Total Revenue (TTM) | 4.04B | |||
| Revenue Per Share | $17.40 | |||
| Gross Profit (TTM) | 2.46B | |||
| EBITDA (TTM) | 1.26B | |||
| EBIT (TTM) | 977.20M | |||
| Net Income (TTM) | 744.00M | |||
| Net Income Avl. to Common (TTM) | 744.00M | |||
| Total Revenue Growth (Q YOY) | 0.86% | |||
| Earnings Growth (Q YOY) | -18.46% | |||
| EPS Diluted (TTM) | 3.16 | |||
| EPS Diluted Growth (Q YOY) | -15.53% | |||
| Balance Sheet | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.98B | |||
| Cash Per Share (Q) | $8.52 | |||
| Total Current Assets (Q) | 3.49B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.77B | |||
| Current Ratio (Q) | 3.485 | |||
| Book Value Per Share (Q) | $21.16 | |||
| Total Assets (Q) | 8.73B | |||
| Total Current Liabilities (Q) | 1.00B | |||
| Total Debt (Q) | 2.54B | |||
| Total Liabilities (Q) | 3.96B | |||
| Total Common Equity (Q) | 4.77B | |||
| Cash Flow | HOLX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -698.80M | |||
| Cash from Financing (TTM) | -701.80M | |||
| Net Change in Cash (TTM) | -150.00M | |||
| Levered Free Cash Flow (TTM) | 888.33M | |||
| Cash from Operations (TTM) | 1.25B | |||
